Your browser doesn't support javascript.
loading
KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia.
Iyoda, Shinju; Yoshida, Kenichi; Shoji, Kota; Ito, Nana; Tanaka, Miu; Nannya, Yasuhito; Yamato, Genki; Tsujimoto, Shinichi; Shiba, Norio; Hayashi, Yasuhide; Shiozawa, Yusuke; Shiraishi, Yuichi; Chiba, Kenichi; Okada, Ai; Tanaka, Hiroko; Miyano, Satoru; Koga, Yuhki; Goto, Hiroaki; Moritake, Hiroshi; Terui, Kiminori; Ito, Etsuro; Kiyokawa, Nobutaka; Tomizawa, Daisuke; Taga, Takashi; Tawa, Akio; Takita, Junko; Nishikori, Momoko; Adachi, Souichi; Ogawa, Seishi; Matsuo, Hidemasa.
Afiliación
  • Iyoda S; Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Yoshida K; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Shoji K; Division of Cancer Evolution, National Cancer Center Research Institute, Tokyo, Japan.
  • Ito N; Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Tanaka M; Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Nannya Y; Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Yamato G; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Tsujimoto S; Division of Hematopoietic Disease Control, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Shiba N; Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Hayashi Y; Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Shiozawa Y; Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Shiraishi Y; Institute of Physiology and Medicine, Jobu University, Takasaki, Japan.
  • Chiba K; Laboratory of Molecular Analysis, Nippon Medical School, Tokyo, Japan.
  • Okada A; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.
  • Tanaka H; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.
  • Miyano S; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.
  • Koga Y; Department of Integrated Analytics, M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan.
  • Goto H; Department of Integrated Analytics, M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan.
  • Moritake H; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Terui K; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Ito E; Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Kiyokawa N; Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Tomizawa D; Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Taga T; Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan.
  • Tawa A; Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
  • Takita J; Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan.
  • Nishikori M; Department of Pediatrics, Higashiosaka Aramoto Heiwa Clinic, Higashiosaka, Japan.
  • Adachi S; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ogawa S; Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Matsuo H; Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Leukemia ; 38(7): 1609-1612, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38632314
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Reordenamiento Génico / Leucemia Mieloide Aguda / Proteínas Proto-Oncogénicas p21(ras) / N-Metiltransferasa de Histona-Lisina / Proteína de la Leucemia Mieloide-Linfoide / Mutación Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Reordenamiento Génico / Leucemia Mieloide Aguda / Proteínas Proto-Oncogénicas p21(ras) / N-Metiltransferasa de Histona-Lisina / Proteína de la Leucemia Mieloide-Linfoide / Mutación Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Japón